Related Experiment Video
Updated: Jun 12, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
Infection Dynamics and Host Biomarker Identification for Spotty Liver Disease in Chickens
Helen James1, Emily Gan2, Robert J Moore1
1School of Science, RMIT University, Bundoora, VIC 3083, Australia.
Abstract:
Spotty liver disease (SLD), primarily caused by Campylobacter hepaticus and (less frequently) by Campylobacter bilis, significantly impacts commercial layer hens by causing liver lesions, reducing egg production, and increasing mortality, meaning it can result in serious economic losses for farmers. This study explored the relationship between infection, liver dysfunction, and reproduction, aiming to identify host genetic markers for tracking SLD progression. Hens were orally inoculated with the C. hepaticus strain NSW44L and monitored over a seven-day period. Pathogen colonisation was quantified using qPCR across the liver, bile, caeca, spleen, and ovarian follicles, while liver lesions were scored and hepatic transcriptomes analysed using RNA-seq. C. hepaticus was detected in the liver, caeca, and spleen from one day post-inoculation (dpi) (1.44-1.68 log10 CFU/mL), appeared in bile by the third dpi (3.64 log10 CFU/mL), and reached the follicles by the fourth dpi (3.25 log10 CFU/mL). The highest bacterial loads were found in bile on days six and seven (up to 7.18 CFU/mL). Liver lesions were first observed on the fourth dpi, reaching their peak at the sixth and seventh dpi. Gene expression analysis in liver tissue revealed a notable downregulation of yolk-precursor and metabolic genes, such as prolactin receptor (PRLR), 7-dehydrocholesterol reductase (DHCR7), and malic enzyme 1 (ME1). In contrast, from days three to seven post-infection, there was significant upregulation of avidin (AVD), a biotin-binding protein, and versican (VCAN), which is linked to tissue remodelling and inflammation. These findings correlate with the disease's progression from initial liver infection to widespread bacterial presence, suggesting value as host biomarkers for effective SLD monitoring and the development of targeted therapies.

